NECHAMA SAKAL: Open Payments
NPI 1407574338 · FLUSHING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 16 payments from 10 companies in 2025. Trend: 2023 $16 · 2024 $76 · 2025 $403
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $142 |
| GlaxoSmithKline, LLC. | 6 | $104 |
| PFIZER INC. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Pulmonx Corporation | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
Products named: CEREZYME, NUCALA, PREVNAR 20, BREZTRI, DUPIXENT, PURIFIED CORTROPHIN GEL, Sunosi, ZEPBOUND.
Industry payments across NY — which companies pay providers there.
